ConductScience.org, home

Paper41595154

Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk.

Bruinsma RS and 12 others. Cancers (Basel), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk. Papers, record 41595154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41595154

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Features Associated with a High-Risk Clinical Course in Neuroblastomas Initially Diagnosed as Non-High-Risk.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-31
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bruinsma RSRixt Shttps://orcid.org/0000-0001-8557-4529
2de Leng WWJWendy W Jhttps://orcid.org/0000-0003-2911-6018
3Fiocco MFMarta Fhttps://orcid.org/0000-0001-5588-0277
4Dierselhuis MPMiranda Phttps://orcid.org/0009-0001-6185-5569
5Langenberg KPKarin Phttps://orcid.org/0000-0002-6780-0585
6Molenaar JJJan Jhttps://orcid.org/0000-0002-2007-0431
7Kester LALennart Ahttps://orcid.org/0000-0002-8259-9971
8van Noesel MMMax Mhttps://orcid.org/0000-0003-0503-5838
9Tytgat GAMGodelieve A Mhttps://orcid.org/0000-0003-4452-0748
10van de Ven CPCornelis Phttps://orcid.org/0000-0001-8745-0626
11Wijnen MHWAMarc H W A
12de Krijger RRRonald Rhttps://orcid.org/0000-0001-6871-1296
13Steeg AFWVAlida F W van derhttps://orcid.org/0000-0003-0168-7513

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121862876Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma.Cell Cycle2011https://conductscience.org/library/papers/21862876PubMed
220516441Accumulation of segmental alterations determines progression in neuroblastoma.J Clin Oncol2010https://conductscience.org/library/papers/20516441PubMed
319047291The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.J Clin Oncol2009https://conductscience.org/library/papers/19047291PubMed
435100718Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma.JCO Precis Oncol2019https://conductscience.org/library/papers/35100718PubMed
536162542Tumoral heterogeneity in neuroblastoma.Biochim Biophys Acta Rev Cancer2022https://conductscience.org/library/papers/36162542PubMed
68889347A note on quantifying follow-up in studies of failure time.Control Clin Trials1996https://conductscience.org/library/papers/8889347PubMed
735859155Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.Sci Rep2022https://conductscience.org/library/papers/35859155PubMed
8285612282017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors.Klin Padiatr2017https://conductscience.org/library/papers/28561228PubMed
925741868
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Genet Med2015https://conductscience.org/library/papers/25741868PubMed
1034115544Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).J Clin Oncol2021https://conductscience.org/library/papers/34115544PubMed
1139893454
How much missing data is too much to impute for longitudinal health indicators? A preliminary guideline for the choice of the extent of missing proportion to impute with multiple imputation by chained equations.
Popul Health Metr2025https://conductscience.org/library/papers/39893454PubMed
1225517749ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.Cancer Cell2014https://conductscience.org/library/papers/25517749PubMed
1321632861High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.Clin Cancer Res2011https://conductscience.org/library/papers/21632861PubMed
1439796644Prognostic Value of Molecular Aberrations in Low- or Intermediate-Risk Neuroblastomas: A Systematic Review.Cancers (Basel)2024https://conductscience.org/library/papers/39796644PubMed
1534319759Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.J Clin Oncol2021https://conductscience.org/library/papers/34319759PubMed
1637169874Clonal evolution during metastatic spread in high-risk neuroblastoma.Nat Genet2023https://conductscience.org/library/papers/37169874PubMed
1724045179Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.Clin Cancer Res2013https://conductscience.org/library/papers/24045179PubMed
1834636058Neuroblastoma-Telomere maintenance, deregulated signaling transduction and beyond.Int J Cancer2022https://conductscience.org/library/papers/34636058PubMed
1936807339Genomic ALK alterations in primary and relapsed neuroblastoma.Br J Cancer2023https://conductscience.org/library/papers/36807339PubMed
2030754710The Evolution of Risk Classification for Neuroblastoma.Children (Basel)2019https://conductscience.org/library/papers/30754710PubMed

See all 34 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CDK41019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41595154

GET https://conductscience.org/api/papers/v1/41595154/references?page=2